hsTnT in Patients Admitted to the ED With Atrial Fibrillation in the Era of NOACs - Heidelberg Registry of Atrial Fibrillation
NCT ID: NCT03344237
Last Updated: 2019-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
5000 participants
OBSERVATIONAL
2017-09-14
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Sensitivity Cardiac Troponin T in Patients With Atrial Fibrillation Admitted to an Emergency Department (ED)
NCT02542189
Minor Troponin Elevations in Patients With Atrial Fibrillation
NCT03683836
Risk Indicators in Patients With Ventricular Fibrillation During Acute Myocardial Infarction
NCT00175942
Mi-RNAs and Specificity of Hs-TnT in Symptomatic ED Patients
NCT02116153
hsTnT After Elective Coronary Angiography
NCT01735500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* availability of at least one hsTnT measurement
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Heidelberg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr.med. Dr.med.univ. Mehrshad VAFAIE
Cardiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehrshad Vafaie, Dr.med.Dr.med.univ.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Heidelberg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital
Heidelberg, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mehrshad Vafaie, Dr.med.Dr.med.univ.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HERA-FIB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.